Report Highlights
The global market for advanced orthopedic technologies, implants, and regenerative products is estimated to increase from $66.4 billion in 2023 to reach $84.8 billion by 2028, at a compound annual growth rate (CAGR) of 4.1% from 2023 through 2028.
Report Includes
- 11 tables
- An up-to-date overview and analysis of the global markets for advanced orthopedic technologies, implants and regenerative products
- Analyses of the global market trends, with market revenue data (sales figures) for 2020-2022, forecasts for 2023, and projections of compound annual growth rates (CAGRs) through 2028
- Estimation of the actual market size and revenue forecast for the advanced orthopedic technologies, implants and regenerative products market, and its corresponding market share analysis based on product type and region
- In-depth information (facts and figures) concerning major market dynamics, recent trends and developments, opportunities and challenges estimating the current and future demand, and impact of macroeconomic factors in the progress of this market
- A look at the current industry regulations and developmental procedures and products, along with details of guidelines for orthopedic medical devices quality management and manufacturing practices
- Review of recent patent applications filed on advanced orthopedic technologies implants and regenerative products
- Identification of the major stakeholders and analysis of the competitive landscape based on recent developments, financial performance, and segmental revenues
- Updated information on recent mergers and acquisitions, partnerships, agreements, collaborations, and other strategic alliances within the marketplace
- Company profiles of the leading global players, including B. Braun Melsungen AG, Zimmer Biomet, Medtronic, Nuvasive, and Stryker Corporation
Report Scope
The “Advanced Orthopedic Technologies, Implants and Regenerative Products Market” report analyzes the product types used for orthopedic implants and regeneration. The report is segmented based on device types such as bone repair and regenerative products, cartilage and soft tissue repair, regenerative products, and joint replacement, implants, and regenerative products.
A detailed analysis illustrating market dynamics and market structure is incorporated in the report. Porter’s Five Forces analysis and supply and distribution chain are discussed in detail for an in-depth market understanding. The report covers the current regulations and guidelines for quality management and manufacturing practices of orthopedic medical devices in the context of their use in the advanced orthopedic devices industry. Top market players detailing their business operations and segment focus, revenue, and strategy analysis are included in the report. Market share analysis of leading market players, product launches, and pipeline products are also captured in the information.
Regarding geography, the report analyzes the market across North America, Europe, and Asia-Pacific. Key countries like the U.S., Canada, Mexico, Europe (top five countries), China, India, and Japan are discussed due to a high concentration of orthopedic device manufacturing companies and contract manufacturing organizations in these countries.
The base year for market data is 2022, with historical data provided for 2020 and forecast data provided through 2028. Historical, base year, and forecast data are provided for each market segment of the report.
Report Synopsis
| Report Metrics | Details | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2022 | ||||||||||
| Forecast period considered | 2023-2028 | ||||||||||
| Base year market size | $63.3 billion | ||||||||||
| Market size forecast | $84.8 billion | ||||||||||
| Growth rate | CAGR of 4.1% for the forecast period of 2023-2028 | ||||||||||
| Units considered | $ Millions | ||||||||||
| Segments covered | product type and region | ||||||||||
| Regions covered | North America, Europe, Asia-Pacific, and Rest of the World | ||||||||||
| Key Market Drivers |
|
||||||||||
| Companies studied |
|
||||||||||
Frequently Asked Questions (FAQs)
- B Braun
- Johnson & Johnson
- Novartis
- Stryker
- Medtronic
Analyst Credentials
Kalyani Kottapenta – Assistant Manager, Life Sciences
Kalyani Kottapenta is a research professional with nine years of experience in the life sciences and healthcare industry. Her expertise in qualitative and quantitative market information, including market dynamics like market sizing, advanced excel based market modeling, data analysis, forecasting, company share analysis, and competitive landscape assessment of the medical device industry, developing custom reports. She holds a master’s degree in Microbiology and a bachelor’s in Biotechnology and Chemistry.
Report Highlights
The global advanced orthopedic technologies, implants, and regenerative products market totaled $44.7 billion in 2018 and is estimated to reach $56.2 billion by 2023, growing at a compound annual growth rate (CAGR) of 4.7% for the period of 2018-2023.
Report Includes
- 18 data tables and 44 additional tables
- Country specific data and analysis for China, India, Japan, Australia, UK, Germany, France, Italy, Spain, Russia, USA, Canada, Mexico and Brazil
- An overview of the advanced orthopedic technologies, implants, and regenerative products used for the treatment of orthopedic disorders such as arthritis, fractures, joint inflammation and rheumatoid joint pain
- Description about the market trends, drivers, restraints, and future opportunities
- Coverage of current regulations and guidelines for orthopedic medical devices quality management and manufacturing practices
- Analysis of the company profiles of the industry, including Smith & Nephew plc., Medtronic Inc., Exactech, Inc., and B. Braun Melsungen Ag, Zimmer Biomet Holdings Inc.
Report Highlights
BCC Research estimates that the global market for advanced orthopedics will grow from $35.3 billion in 2013 to nearly $36.4 billion in 2014, continuing to increase at a compound annual growth rate (CAGR) of 3.0% for the period of 2014 to 2019 reaching nearly $42.2 billion in 2019.
Report Includes
- An overview of the global market for advanced orthopedic technologies, implants, and regenerative products.
- Analyses of global market trends, with data from 2013, estimates for 2014, and projections of compound annual growth rates (CAGRs) through 2019.
- A look at how new items and biotechnological advancements are beginning to revolutionize future growth of the orthopedic device market.
- Segmented analysis based on product categories, product uses, forecasts, as well as competitive analyses.
- Comprehensive profiles of major players in the field.
Report Highlights
The total market for advanced orthopedic technology and products was estimated to exceed $28 billion in 2010. New technologies and an increasingly older population are two of the major driving forces within the market. By 2015, the advanced orthopedic technology and product market is likely to reach $32.4 billion, with a compound annual growth rate (CAGR) from 2010 to 2015 of 2.7%.
Report Highlights
-
The total market for advanced orthopedic technology and products was estimated to exceed $17.5 billion in 2006, up 11.7% from $15.7 billion the previous year (2005). By 2012, the advanced orthopedic technology and product market is likely to reach $31.9 billion, with average growth estimated at 10.3%.
-
Worldwide, the bone repair and regenerative product market has increased at a rate of 19% to 22% annually over the past several years. In 2006, the market experienced a 22% increase over the $910 million in 2005 to reach $1.1 billion.
-
Worldwide, the total joint replacement, implant and regenerative product markets generated approximately $15.8 billion in 2006, an increase of 11.4% over $11.2 billion estimated for 2005.
Related Reports
Global Orthodontic and Orthopedic Market
The global market for orthodontic devices is expected to grow from $18.9 billion in 2023 and projected to reach $29.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.2% during the forecast period of 2023 to 2028.Report Includes
Global Market for Pain Management Drugs and Devices
The global market for pain management drugs and devices is expected to increase from $84.6 billion in 2023 to $109.9 billion by the end of 2028, with a compound annual growth rate (CAGR) of 5.4% during the forecast period of 2023-2028.
The Market for Minimally Invasive Medical Devices
The global minimally invasive medical devices market should reach $41.0 billion by 2028 from $28.5 billion in 2023 at a compound annual growth rate (CAGR) of 7.6% for the forecast period of 2023 to 2028.
Advanced Orthopedic Technologies, Implants and Regenerative Products
The global market for advanced orthopedic technologies, implants, and regenerative products is estimated to increase from $66.4 billion in 2023 to reach $84.8 billion by 2028, at a compound annual growth rate (CAGR) of 4.1% from 2023 through 2028.
Recent Reports
Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets
The global market for radiation therapy products and radiopharmaceuticals is expected to grow from $17.5 billion in 2024 and is projected to reach $31.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.3% during the forecast period of 2024 to 2029.
Routine Health Screening Market
The global market for routine health screening is expected to grow from $59.7 billion in 2024 and is projected to reach $82.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2024 to 2029.
Elder Care Services and Assistive Devices: Global Markets
The global market for elder care services and assistive devices is expected to grow from $868.2 billion in 2024 and is projected to reach $1.1 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 5.8% during the forecast period of 2024 to 2029.
Direct-to-Consumer Testing Industry: Global Markets
The global market for direct-to-consumer (DTC) testing is estimated to increase from $1.6 billion in 2023 to reach $3.2 billion by 2029, at a compound annual growth rate (CAGR) of 12.5% from 2024 through 2029.
Health and Medical Insurance Providers: Global Markets
The global market for health and medical insurance providers is expected to grow from $2.2 trillion in 2023 to $3.4 trillion by the end of 2028, at a compound annual growth rate (CAGR) of 8.9% during the forecast period of 2023 to 2028.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More